- GenScript Biotech officially joins SBTi to fulfill its sustainability commitment
- GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance
- GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%
- Dr. David Liu Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy
- Immunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs
- GenScript Announces Its Inaugural Life Science Research Grant Project
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.44 |
---|---|
High | 11.44 |
Low | 10.34 |
Bid | 10.44 |
Offer | 10.46 |
Previous close | 11.46 |
Average volume | 15.42m |
---|---|
Shares outstanding | 2.12bn |
Free float | 1.15bn |
P/E (TTM) | -- |
Market cap | 24.34bn HKD |
EPS (TTM) | -0.3549 HKD |
Data delayed at least 15 minutes, as of Apr 19 2024 09:08 BST.
More ▼